DMD and Duchenne muscular dystrophy: Furthermore, although systemic genetic therapy is showing promise in the treatment of DMD, there is some concern for the immunogenicity of dystrophin, as this protein is not recognised as own in DMD patients, who have never synthesised normal dystrophin.